Are you up on the latest in product and process development? Join us to broaden your knowledge and to discuss technical issues such as scale-up problems as well as non-technical issues, including effective communication with managers and other functions.

11 months after the worst nuclear disaster since Chernobyl, two new US reactors got the green light from governing body NRC. This is wonderful news for the nuclear industry, but while some have visions of the long-awaited nuclear renaissance, it may be too soon to start ringing the victory bell.

Welcome to the ninth comic in the Boil's Laws comic strip series. So, how do chemical engineers and chemists see the world differently? Click and find out.

Although tidal energy is a micro-niche market over-shadowed by wind and solar, global giant Siemens has recently upped its stake from 45 to 90 percent in tidal energy pioneer, Marine Current Turbines (MCT). Currently, the small, 25-employee, UK-based company has only one grid-connected prototype, which may not appear very auspicious.

Pilgrim studios and the Discovery channel have teamed up to bring the new reality show competition "Top Engineer" to life. This competition show will bring together a handful of men and women to compete in challenges from various engineering disciplines at the WET facilities in California.

This year's meeting, Bionanoscience and Bioengineering for Translational Medicine, will foster greater knowledge exchange and collaboration in the areas of bioengineering and nanotechnology – two interdisciplinary fields that cut across and integrate various areas in science, engineering, and medicine to create breakthroughs in biomedical research.

This week is the 61st National Engineers Week, a time to reflect on and celebrate the accomplishments of our profession, as well as a time to plan for its future through outreach and awareness campaigns.

Researchers at the Cedars-Sinai Heart Institute in Los Angeles just peeled back some of the mystery shrouding the heart to prove the potential for stem cell use in repairing heart tissue after heart attacks. The small-scale randomized phase-one trial followed 31 patients who had recently had a myocardial infarction for more than two years.